[1]Pilipchuk SP, Plonka AB, Monje A, et al. Tissue engineering for bone regeneration and osseointegration in the oral cavity. Dent Mater. 2015;31(4):317-338.[2]常晓朋,陈涛,赵寅,等.骨形态发生蛋白2和转化生长因子β2协同促进骨髓间充质干细胞成骨分化[J].中国组织工程研究,2019, 23(1):1-6.[3]Trento GS, Carvalho PHA, Macedo DV, et al. Titanium mesh associated with rhBMP-2 in alveolar ridge reconstruction. Int J Oral Maxillofac Surg. 2018. DOI:10.1016/j.ijom.2018.09.015[4]Poon B, Kha T, Tran S, et al. Bone morphogenetic protein-2 and bone therapy: successes and pitfalls. J Pharm Pharmacol. 2016;68(2):139-147.[5]Mussano F, Ciccone G, Ceccarelli M, et al. Bone morphogenetic proteins and bone defects: a systematic review. Spine (Phila Pa 1976). 2007;32(7):824-830.[6]Hreha J, Krell E S, Bibbo C. Role of Recombinant human bone morphogenetic protein-2 on hindfoot arthrodesis. Foot Ankle Clin. 2016;21(4):793-802.[7]Katayama Y, Matsuyama Y, Yoshihara H, et al. Clinical and radiographic outcomes of posterolateral lumbar spine fusion in humans using recombinant human bone morphogenetic protein-2: an average five-year follow-up study. Int Orthop. 2009;33(4):1061-1067.[8]刘启省,张东刚.重组人骨形态发生蛋白2/骨修复材料的制备与性能[J].中国组织工程研究,2016,20(38):5664-5671.[9]Herford AS. The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma. Chin J Traumatol. 2017;20(1):1-3.[10]Kwak EJ, Cha IH, Nam W, et al. Effects of locally administered rhBMP-2 and bisphosphonate on bone regeneration in the rat fibula. Oral Dis. 2018;24(6): 1042-1056.[11]Carlisle P, Guda T, Silliman DT, et al. Localized low-dose rhBMP-2 is effective at promoting bone regeneration in mandibular segmental defects. J Biomed Mater Res B Appl Biomater. 2018. DOI: 10.1002/jbm.b.34241.[12]Nam JW, Kim HJ. Stepwise verification of bone regeneration using recombinant human bone morphogenetic protein-2 in rat fibula model. J Korean Assoc Oral Maxillofac Surg. 2017; 43(6):373-387.[13]Pan ZX, Zhang HX, Wang YX, et al. Effect of recombinant human bone morphogenetic protein 2/poly-lactide-co-glycolic acid (rhBMP-2/PLGA) with core decompression on repair of rabbit femoral head necrosis. Asian Pac J Trop Med. 2014; 7(11):895-899.[14]Skelly JD, Lange J, Filion TM, et al. Vancomycin-bearing synthetic bone graft delivers rhBMP-2 and promotes healing of critical rat femoral segmental defects. Clin Orthop Relat Res. 2014;472(12):4015-4023.[15]Baltzer AW, Ostapczuk MS, Stosch D, et al. The use of recombinant human bone morphogenetic protein-2 for the treatment of a delayed union following femoral neck open-wedge osteotomy. Orthop Rev (Pavia). 2012;4(1):e4.[16]Lykissas M, Gkiatas I. Use of recombinant human bone morphogenetic protein-2 in spine surgery. World J Orthop. 2017;8(7):531-535.[17]胡思科,罗任,劳世高,等.经空心加压螺钉隧道重组人骨形态发生蛋白2植入术治疗股骨颈骨折的临床观察[J].现代医院, 2018, 18(5):747-749,752.[18]刘军,王刚,谷贵山,等.开放性骨折的治疗[J].中国矫形外科杂志, 2007,15(24):1878-1881.[19]苏晨晨,张文生,刘世平,等.中青年股骨颈骨折空心螺钉内固定术后股骨头坏死的相关因素分析[J].局解手术学杂志,2018,27(9): 665-669.[20]Sun W, Li Z, Gao F, et al. Recombinant human bone morphogenetic protein-2 in debridement and impacted bone graft for the treatment of femoral head osteonecrosis. PLoS One. 2014;9(6):e100424.[21]Shi L, Sun W, Gao F, et al. Heterotopic ossification related to the use of recombinant human BMP-2 in osteonecrosis of femoral head. Medicine (Baltimore). 2017;96(27):e7413.[22]Gao F, Sun W, Guo W, et al. Combined with bone marrow-derived cells and rhbmp-2 for osteonecrosis after femoral neck fractures in children and adolescents: a case series. Sci Rep. 2016;6:30730.[23]Hissnauer TN, Stiel N, Babin K, et al. Recombinant human bone morphogenetic protein-2 (rhbmp-2) for the treatment of nonunion of the femur in children and adolescents: a retrospective analysis. Biomed Res Int. 2017;2017:3046842.[24]Oetgen ME, Richards BS. Complications associated with the use of bone morphogenetic protein in pediatric patients. J Pediatr Orthop. 2010;30(2):192-198.[25]张濒.应用解剖锁定钢板及rhBMP-2治疗股骨远端粉碎性骨折的疗效观察[C].中国转化医学和整合医学学术交流会(上海站), 2015. [26]李飞,庞彬.开放性胫骨骨折内固定术后感染的危险因素和病原菌分析[J].解放军医药杂志,2018,30(11):55-57, 61.[27]Bosse MJ, Mackenzie EJ, Kellam JF, et al. An analysis of outcomes of reconstruction or amputation after leg-threatening injuries. N Engl J Med. 2002;347(24): 1924-1931.[28]Govender S, Csimma C, Genant HK, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002; 84-A(12):2123-2134.[29]Aro H T, Govender S, Patel AD, et al. Recombinant human bone morphogenetic protein-2: a randomized trial in open tibial fractures treated with reamed nail fixation. J Bone Joint Surg Am. 2011;93(9):801-808.[30]Barcak EA, Beebe MJ. Bone morphogenetic protein: is there still a role in orthopedic trauma in 2017? Orthop Clin North Am. 2017;48(3):301-309.[31]Alt V, Borgman B, Eicher A, et al. Effects of recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) in grade III open tibia fractures treated with unreamed nails-A clinical and health-economic analysis. Injury. 2015;46(11):2267-2272.[32]Lyon T, Scheele W, Bhandari M, et al. Efficacy and safety of recombinant human bone morphogenetic protein-2/calcium phosphate matrix for closed tibial diaphyseal fracture: a double-blind, randomized, controlled phase-II/III trial. J Bone Joint Surg Am. 2013;95(23):2088-2096.[33]Richards BS, Anderson TD. rhBMP-2 and intramedullary fixation in congenital pseudarthrosis of the tibia. J Pediatr Orthop. 2018;38(4):230-238.[34]Stiel N, Hissnauer TN, Rupprecht M, et al.Evaluation of complications associated with off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in pediatric orthopaedics. J Mater Sci Mater Med. 2016;27(12):184.[35]Konda SR, Davidovitch RI, Egol KA. Initial surgical treatment of humeral shaft fracture predicts difficulty healing when humeral shaft nonunion occurs. HSS J. 2016;12(1):13-17.[36]谢纪宝,郑永茂,李云飞,等.β-磷酸三钙人工骨联合rhBMP-2重建肱骨近端良性骨肿瘤及骨瘤样病变刮除[J].华夏医学,2018, 31(1):39-41.[37]Von Ruden C, Morgenstern M, Hierholzer C, et al. The missing effect of human recombinant bone morphogenetic proteins BMP-2 and BMP-7 in surgical treatment of aseptic forearm nonunion. Injury. 2016;47(4):919-924.[38]陈启刚,胡永军,胡海,等.锁定接骨板结合重组人骨形态发生蛋白骨修复材料治疗跟骨骨折的临床分析[J].安徽医药,2018,22(4): 703-706.[39]Rearick T, Charlton TP, Thordarson D. Effectiveness and complications associated with recombinant human bone morphogenetic protein-2 augmentation of foot and ankle fusions and fracture nonunions. Foot Ankle Int. 2014;35(8): 783-788.[40]Rice I, Lubahn J D.Use of bone morphogenetic protein-2 (rh-BMP-2) in treatment of wrist and hand nonunion with comparison to historical control groups. J Surg Orthop Adv. 2013;22(4):256-262.[41]Ronga M, Fagetti a, Canton G, et al. Clinical applications of growth factors in bone injuries: experience with BMPs. Injury. 2013;44 Suppl 1:S34-S39.[42]Ritting AW, Weber EW, Lee MC. Exaggerated inflammatory response and bony resorption from BMP-2 use in a pediatric forearm nonunion. J Hand Surg Am. 2012;37(2):316-321.[43]Patel AD. Bone morphogenetic proteins in orthopaedic trauma: recent clinical findings with human bone morphogenetic protein-2 (rhBMP-2). Curr Med Res Opin. 2006;22 Suppl 1:S1-S5.[44]汤显能,陈跃平,章晓云.骨与软骨组织工程中骨形态发生蛋白的研究与临床应用[J].中国组织工程研究,2019,23(4):591-596.[45]Das SP, Ganesh S, Pradhan S, et al. Effectiveness of recombinant human bone morphogenetic protein-7 in the management of congenital pseudoarthrosis of the tibia: a randomised controlled trial. Int Orthop. 2014;38(9): 1987-1992.[46]Papanagiotou M, Dailiana ZH, Karachalios T, et al. Heterotopic ossification after the use of recombinant human bone morphogenetic protein-7. World J Orthop. 2017;8(1): 36-41.[47]Li R, Ma Y, Zhang Y, et al. Potential of rhBMP-2 and dexamethasone-loaded Zein/PLLA scaffolds for enhanced in vitro osteogenesis of mesenchymal stem cells. Colloids Surf B Biointerfaces. 2018;169:384-394.[48]Bae EB, Park KH, Shim JH, et al. Efficacy of rhBMP-2 loaded PCL/beta-TCP/bdECM scaffold fabricated by 3D printing technology on bone regeneration. Biomed Res Int. 2018; 2018:2876135.[49]Zhou P, Xia Y, Cheng X, et al. Enhanced bone tissue regeneration by antibacterial and osteoinductive silica-HACC-zein composite scaffolds loaded with rhBMP-2. Biomaterials. 2014;35(38):10033-10045.[50]Kuroiwa Y, Niikura T, Lee SY, et al. Escherichia coli-derived BMP-2-absorbed beta-TCP granules induce bone regeneration in rabbit critical-sized femoral segmental defects. Int Orthop. 2018. DOI: 10.1007/s00264-018-4079-4.[51]Boraiah S, Paul O, Hawkes D, et al. Complications of recombinant human BMP-2 for treating complex tibial plateau fractures: a preliminary report. Clin Orthop Relat Res. 2009; 467(12):3257-3262.[52]Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J. 2011;11(6):471-491.[53]Smucker JD, Rhee JM, Singh K, et al. Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine (Phila Pa 1976). 2006; 31(24):2813-2819.[54]Matthews JR, Margolis DS, Wu E, et al. Brachial plexopathy following use of recombinant human bmp-2 for treatment of atrophic delayed union of the clavicle. JBJS Case Connect. 2015;5(3):e81-e85.[55]Chan D, Garland J, Infante A, et al.Wound complications associated with bone morphogenetic protein-2 in orthopaedic trauma surgery. J Orthop Trauma. 2014;28(10):599-604.[56]Lad SP, Bagley JH, Karikari IO, et al. Cancer after spinal fusion: the role of bone morphogenetic protein. Neurosurgery. 2013;73(3):440-449.[57]Carragee EJ, Chu G, Rohatgi R, et al. Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis. J Bone Joint Surg Am. 2013;95(17):1537-1545.[58]Egashira K, Sumita Y, Zhong W, et al. Bone marrow concentrate promotes bone regeneration with a suboptimal-dose of rhBMP-2. PLoS One. 2018;13(1): e0191099.[59]De Biase P, Capanna R. Clinical applications of BMPs. Injury. 2005;36 Suppl 3:S43-S46.[60]Takemoto R, Forman J, Taormina DP, et al. No advantage to rhBMP-2 in addition to autogenous graft for fracture nonunion. Orthopedics. 2014;37(6):e525-530. |